Duodenal pulsENDO for Suboptimally Controlled Type II Diabetes Mellitus and Steatotic Liver Disease

Clinical trial NCT07390422 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07390422
Sponsor: Chinese University of Hong Kong
Status: NOT_YET_RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

T2DM (Type 2 Diabetes Mellitus)MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease Metabolic Syndrome (MetS)

Start date: 2026-09-01
Primary completion: 2031-08-30
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.